Contact Us

Life Sciences

Integrated Project Management Company, Inc. (IPM) is an industry leader in Life Sciences consulting.

IPM’s experience within the Life Sciences industry is broad and deep. For more than 30 years, we’ve managed thousands of projects for more than 150 biotech, pharmaceutical, cell and gene therapy, and medical technology companies. Our clients range from startups to some of the world’s largest firms. We work onsite with your cross-functional experts to lead your critical projects and to ensure you meet your goals—efficiently, economically, and often ahead of schedule.

Our consultants, working individually or as a team, bring a wealth of industry experience, valuable leadership, and problem solving skills, and apply state of the art project management practices.  Our consultants have an average of 20 years’ experience and are Project Management Institute (PMP) certified. Most also hold advanced degrees (PhDs, MBAs, MS) and other certifications (Six Sigma, Lean, RAC).


Engage IPM For:

Hands on leadership of product development across the full product life cycle 

  • Research and development
  • Clinical development
  • Regulatory submissions
  • Commercial launch
  • Product lifecycle management
  • Pharmaceutical serialization

Create new or improve existing operational processes:

Responding to urgent corporate needs or organizational change

  • Managing timely and successful EU MDR implementation at every functional level
  • Assessing, diagnosing, and solving organizational/team problems
  • Mitigation of product quality regulatory problems, including recalls and remediations (e.g. 483 letters, Complete Response Letters)
  • Meeting the compliance timelines for serialization of the drug supply chain
  • Mergers and acquisitions, divestitures
  • Changing the way your business operates

Contact us about your project.

Client Testimonials

testimonial icon - quotation mark and speech bubble

“IPM provides more than just project management support; they share ownership for project deliverables and milestones. When I go to bed at night concerned about a project, I know the IPM project manager is worrying along with me.”

John Ludwig, Ph.D, Senior Vice President of Medicinal Sciences, Pfizer

testimonial icon - quotation mark and speech bubble

“IPM has two attributes that differentiate them: the first is true commitment to client success; the second is their proactive approach to leveraging the collective talent of IPM. Their commitment to client success was exemplified by the time invested in getting to know not just my team but also our interfaces and stakeholders. When it comes to the breadth of IPM expertise, I was impressed by their rapid and effective engagement of experts from the Centers of Excellence, which facilitated delivery of solutions that met the breadth of our needs."

Vice President, Global Quality Analytical Science & Technology, who has engaged IPM at two top-tier biopharmaceutical companies

testimonial icon - quotation mark and speech bubble

"IPM left an indelible mark. Our consultant left us with structures and processes in place that allow us to continue tracking and building our portfolio of projects and to communicate the value of our projects back to the rest of the organization."

Director, Product Management, Pharmaceutical Company

testimonial icon - quotation mark and speech bubble

“We were aware that if we hired an IPM project manager, there would be a whole system of knowledge behind that person that would really help us as we were going through new transitions for our company—preparing for NDA, preparing for commercial—and help us better anticipate what would be ahead of us and plan for that.”

Ericka Benson, VP, Portfolio and Program Management, Catabasis Pharmaceuticals Inc.

Featured Articles

How Alliance Managers Power BioPharma Collaborations

Pharmaceutical and biotechnology companies form alliances to accelerate new drug development and commercialization. These collaborations let companies share financial and operational risks while they leverage…

Read Article

Keeping a Pharma Giant‒Startup Alliance in Balance

Product development alliances between global pharmaceutical giants and startup companies can be a win-win. They offer startups resources and reach, while larger entities gain access…

Read Article

Working Together to Accelerate Regulatory Submissions

“How can we submit sooner?” It’s long been the most common question a regulatory submissions team hears. Executive leaders have ambitious goals in mind for…

Read Article

Untangling CRO Contracts Leads to Supplier Management Best Practices

It doesn’t matter how brilliant the researchers are or how many lives their potential new drug will save. Scientists can’t develop a new pharmaceutical on…

Read Article

Putting the Pieces in Place to Support IND Submissions — and an IPO

Drug discovery, development, and commercialization is like a puzzle. The end may be easy to visualize, but there are many pieces that need to be…

Read Article

A Focus on Collaboration Gets CMC Back on Track, Increasing Efficiency and Solidifying a Round of Funding

The product development timeline for a new pharmaceutical is fragile. If one link in the chain breaks, it delays everything else, including clinical trials, regulatory…

Read Article

Improve Your Regulatory Submissions by Setting, Tracking, and Using the Right Metrics

There’s an adage that says what gets measured gets improved. Regulatory submissions are no exception. And with the growing complexity of clinical trials and increasing…

Read Article

An Agile Approach Helps Optimize Digital Pathology System

The potential gains from digital pathology are endless. The ability to capture, curate, analyze, and rapidly share information about the effects of newly developed molecules…

Read Article

How to Guide a Medtech M&A Integration to Achieve its Long-Term Benefits

Companies often begin achieving some business benefits of a merger or acquisition as soon as the two entities become one. And forward-looking organizations are eager…

Read Article